08048036315
Premium Exporter of Genuine KRYXANA 200mg Tablets from India to Singapore – Orchard | Phoenix Exim

1. General Information

Kryxana 200 mg is an oral oncology medicine containing ribociclib. It is a targeted treatment that works on specific proteins involved in the division and growth of cancer cells. The medicine is generally prescribed together with hormonal treatment rather than being used alone.

  • Brand: Kryxana
  • Strength: 200 mg
  • Active ingredient: Ribociclib
  • Dosage form: Film-coated tablet
  • Therapeutic class: Antineoplastic / CDK4/6 inhibitor
  • Route: Oral
  • Prescription: Required
  • Common pack size: 21 tablets
  • Marketer in India: Novartis India Ltd

2. Product Information

Each Kryxana 200 mg film-coated tablet contains ribociclib succinate equivalent to 200 mg of ribociclib. Official product information describes the tablet as a light greyish-violet, round, film-coated tablet.

Kryxana is a targeted anticancer therapy and may be prescribed with an aromatase inhibitor or fulvestrant depending on the patient's cancer characteristics and treatment history.

3. Uses of Kryxana 200 mg

Kryxana 200 mg is used for specific forms of HR-positive, HER2-negative breast cancer. Depending on the approved indication and treatment setting, it may be used for:

  • Advanced or metastatic HR-positive/HER2-negative breast cancer.
  • Certain patients receiving endocrine-based therapy.
  • Treatment in combination with an aromatase inhibitor.
  • Treatment in combination with fulvestrant in appropriate patients.

The exact indication depends on the patient's disease stage, menopausal status, previous treatment, and local prescribing guidelines.

4. Benefits of This Medicine

When appropriately prescribed, ribociclib can help slow the growth and progression of certain breast cancer cells. By inhibiting CDK4 and CDK6, it interferes with the cell cycle and reduces the ability of cancer cells to multiply.

Potential treatment benefits include:

  • Helps control the growth of HR-positive/HER2-negative breast cancer.
  • Helps delay disease progression in appropriate patients.
  • Provides a targeted treatment approach.
  • Can complement endocrine therapy when used as prescribed.

The expected benefit varies considerably between patients and should be assessed by an oncology specialist.

5. Side Effects of Kryxana 200 mg

Like other anticancer medicines, Kryxana may cause side effects. Important possible adverse effects include:

  • Reduced white blood cell count/neutropenia
  • Nausea
  • Fatigue
  • Diarrhea
  • Vomiting
  • Constipation
  • Headache
  • Hair loss
  • Reduced appetite
  • Liver-enzyme abnormalities
  • Increased risk of infections

Some adverse effects can be serious. Ribociclib can also affect the QT interval of the heart and liver function, so appropriate medical monitoring is important.

6. Common Side Effects

Commonly reported side effects include:

  1. Low white blood cell count
  2. Tiredness or fatigue
  3. Nausea
  4. Diarrhea
  5. Vomiting
  6. Constipation
  7. Headache
  8. Hair loss
  9. Back pain
  10. Decreased appetite

Not every patient experiences these effects, and their severity can vary.

7. How to Use Kryxana 200 mg

Take Kryxana exactly as prescribed by your oncologist.

General administration information includes:

  • Take the tablet orally with or without food.
  • Swallow the tablet whole with water.
  • Do not crush, chew, or break the tablet unless specifically instructed by your healthcare professional.
  • Take it at approximately the same time each day.
  • Treatment commonly follows a 21-days-on/7-days-off cycle, but the exact regimen can vary according to the prescribed treatment plan.
  • Do not change the dose or treatment schedule yourself.

If a dose is missed or vomiting occurs after taking the medicine, follow the instructions provided by your treating doctor rather than taking an extra dose without advice.

8. How Kryxana 200 mg Works

Kryxana contains ribociclib, which is a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor.

CDK4 and CDK6 are proteins involved in controlling the cell cycle. Ribociclib blocks these proteins, helping prevent susceptible cancer cells from progressing through the cell cycle and multiplying. This can slow the growth and progression of certain breast cancers.

9. Safety Advice

Because Kryxana is a prescription anticancer medicine, it should be used under specialist supervision.

Important precautions:

  • Regular complete blood counts (CBC) may be required because ribociclib can reduce blood-cell counts.
  • Liver-function monitoring may be required because the medicine can affect liver enzymes.
  • ECG/electrolyte monitoring may be recommended because ribociclib can prolong the QT interval.
  • Inform your doctor about all medicines, supplements, and herbal products you take because ribociclib has important drug interactions.
  • Tell your doctor if you have liver problems, heart-rhythm problems, or electrolyte abnormalities.
  • Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding. Ribociclib can cause fetal harm.
  • Effective contraception may be required during treatment according to medical advice.
  • Seek medical attention promptly for fever, signs of infection, fainting, abnormal heartbeat, severe breathing difficulty, unusual bleeding, or yellowing of the skin/eyes.

Storage: Product information may vary by market and formulation, so follow the storage instructions printed on the supplied pack and its local prescribing information. Some Indian pharmacy listings specify refrigerated storage at 2–8°C, while other market product information gives different storage conditions; therefore, the specific product label should be followed.

10. Frequently Asked Questions (FAQs)

Q1. What is Kryxana 200 mg used for?
Kryxana 200 mg is used for certain HR-positive, HER2-negative breast cancers, particularly advanced or metastatic disease, in combination with appropriate endocrine therapy.

Q2. What is the active ingredient in Kryxana 200 mg?
The active ingredient is ribociclib, equivalent to 200 mg per tablet.

Q3. Is Kryxana 200 mg a chemotherapy medicine?
It is an oral targeted anticancer medicine and belongs to the CDK4/6 inhibitor class rather than conventional cytotoxic chemotherapy.

Q4. Can Kryxana be taken without food?
Yes. It may generally be taken with or without food, according to the prescribing information.

Q5. Can I crush or chew Kryxana tablets?
No. The tablet should generally be swallowed whole with water.

Q6. Does Kryxana require regular blood tests?
Yes. Blood counts and liver function may need regular monitoring during treatment. ECG and electrolyte monitoring may also be required in appropriate patients.

Q7. Can Kryxana be used during pregnancy?
Ribociclib may cause fetal harm. Patients who are pregnant, planning pregnancy, or breastfeeding should discuss treatment with their oncologist before using it.

Q8. Can I take other medicines with Kryxana?
Some medicines can interact significantly with ribociclib. Always provide your doctor with a complete list of prescription medicines, OTC medicines, supplements, and herbal products before starting treatment.

Q9. Is Kryxana available in different strengths?
Ribociclib products are available in different tablet strengths, including 200 mg; the appropriate dose and number of tablets are determined by the prescribing oncologist.

Q10. Is Kryxana available for export from India?
Availability and export eligibility depend on the product, destination-country regulations, prescription requirements, and applicable pharmaceutical export rules.

11. Substitutes for Kryxana 200 mg

Kryxana's active ingredient is ribociclib. Other brands or generic products containing ribociclib may be considered alternatives, but they should not be substituted independently.

Potential alternatives may include products containing:

  • Ribociclib 200 mg
  • Other ribociclib brands/generic formulations approved in the destination country

Other CDK4/6 inhibitors, such as palbociclib or abemaciclib, are not direct substitutes because they contain different active ingredients and have different dosing, safety profiles, interactions, and approved indications. A treating oncologist should select the appropriate alternative.

12. Keywords

Primary Keywords:

  • Kryxana 200 mg Tablets
  • Kryxana 200 mg Tablet
  • Kryxana 200 mg
  • Ribociclib 200 mg Tablets
  • Ribociclib 200 mg
  • Kryxana Ribociclib Tablets
  • Ribociclib breast cancer medicine
  • CDK4/6 inhibitor tablets
  • HR positive HER2 negative breast cancer medicine
  • Advanced breast cancer treatment

B2B / Export Keywords:

  • Kryxana 200 mg Tablets exporter from India
  • Kryxana 200 mg supplier India
  • Ribociclib 200 mg exporter India
  • Ribociclib tablets supplier from India
  • Kryxana 200 mg pharmaceutical exporter
  • Kryxana 200 mg medicine exporter Nagpur
  • Ribociclib 200 mg medicine exporter Nagpur
  • Kryxana 200 mg wholesale supplier India
  • Kryxana 200 mg international pharmaceutical supplier
  • Kryxana 200 mg export supplier
  • Ribociclib 200 mg export from India
  • Oncology medicine exporter from India
  • Anti-cancer medicine exporter Nagpur
  • Breast cancer medicine supplier India
  • Oncology pharmaceutical exporter India
  • Kryxana supplier USA
  • Kryxana supplier UK
  • Kryxana supplier Australia
  • Kryxana supplier Singapore
  • Kryxana supplier Canada
  • Kryxana supplier South Korea
  • Kryxana supplier UAE
Aug 20th, 2026 3:17 PM

Keywords